To further address whether KRasG13D mutation correlates with PDIA1 expression, we performed RNAseq analysis comparing CRC cell lines presenting KRasG13D mutation (HCT116, HCT15) vs. non-mutated KRas (Caco2) (Table 1). The gene discussed is P4HB; the disease is colorectal carcinoma.